A tailored approach to estimate the outlook of the gene therapy market
Using epidemiological data, a patient-based forecasting model projected the gene therapy market outlook until 2036, evaluating global developments and their impact. Despite uncertainties, it emphasized the importance of preparedness and sustainability for public health resource stakeholders.
